Jade Biosciences Inc Share Price

NASDAQ: JBIO

Large Cap

$6.97

-0.17

(-2.38%)

as on September 18, 2025 at 1:29 am IST

$₹

Jade Biosciences Inc Stock Performance

as on September 18, 2025 at 1:29 am IST

Day's Low
Day's High
$6.94
Day's Price Range
$7.37
$6.97
0.43%
Downside
5.74%
Upside
52 Week's Low
52 Week's High
$6.57
52-Week Price Range
$13.5
$6.97
5.81%
Downside
93.70%
Upside

Jade Biosciences Inc share price movements today

Previous Close: $7.14
Open: $7.37
Volume: 200.7K
Day's Low - High: $6.94 - $7.37
52 Week Low - High: $6.57 - $13.5

Jade Biosciences Inc Historical Returns

1 Month Return: -3.94 %
3 Month Return: -14.72 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Jade Biosciences Inc Stock Fundamentals & Key Indicators

Check Jade Biosciences Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$280.1M

EPS (TTM)

Dividend Yield

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

Return On Equity TTM

0.00%

Jade Biosciences Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Jade Biosciences Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Jade Biosciences Inc	NA	$280.1M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$60.5B	252.04%	-505.15	-12.96%
Beone Medicines Ltd	NA	$39.0B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$100.3B	44.17%	27.85	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.6B	1.78%	14.1	31.37%

Jade Biosciences Inc Stock's Interest Amongst Investors

Search interest for Jade Biosciences Inc Stock has decreased by -54% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 19, 2025 to September 18, 2025

Change:-54% versus previous 30 day period

Jade Biosciences Inc Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2024	Jun 2025
Total Revenue	-	-
Gross Profit	0	0
Operating Income	-15	-27
EBITDA	-16	-32
Interest Expense	-	-
Depreciation	-	-
Income Before Tax	-16	-32
Income Tax Expense	-	-
Net Income	-16	-32
Net Profit Margin	0.00%	0.00%

Jade Biosciences Inc Annual Profit & Loss

All numbers in Millions USD


Total Revenue
Gross Profit
Operating Income
EBITDA
Interest Expense
Depreciation
Income Before Tax
Income Tax Expense
Net Income
Net Profit Margin

Jade Biosciences Inc Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-20	-23	-24	-16	-5	-38	-32
Operating Cash Flow	-14	-23	-20	-16	-11	-	-36
Investing Cash Flow	5	8	18	16	13	-	-12
Financing Cash Flow	0	0	24	0	0	-	190
Change in Cash	-8	-14	21	0	2	-	176

Jade Biosciences Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-22	-51	-75	0
Operating Cash Flow	-27	-39	-56	-71
Investing Cash Flow	-113	6	11	56
Financing Cash Flow	190	0	45	25
Change in Cash	49	-31	1	10

Insights on Jade Biosciences Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 1 Year
In the last 1 year, JBIO has outperformed top 5 stocks with highest market-cap in its industry
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 171.1%
NEGATIVE IMPACT
Price Dip
In the last 7 days, JBIO stock has moved down by -8.0%

About Jade Biosciences Inc

Jade Biosciences, Inc. is a biotechnology company, which is focused on developing therapies for autoimmune diseases. The Company’s lead asset, JADE-001, is an investigational anti-A PRoliferation-Inducing Ligand (APRIL) monoclonal antibody for the treatment of Immunoglobulin A (IgA) nephropathy (IgAN), an autoimmune condition in which the kidney is damaged by pathogenic IgA containing immune complexes, leading to proteinuria and kidney function decline, and potentially progressing to end-stage kidney disease requiring dialysis or transplantation. Designed to block the APRIL protein, JADE-001 targets an underlying cause of IgAN, offering the potential to reduce pathogenic IgA levels, decrease proteinuria, and preserve kidney function over the long term. The Company’s pipeline also includes two undisclosed antibody discovery programs: JADE-002 and JADE-003, which are in preclinical development.

Organisation	Jade Biosciences Inc
Headquarters	221 Crescent Street Building 23, Waltham, MA, United States, 02453
CEO	Mr. Tom Frohlich
E-voting on shares	Click here to vote

Key Management of Jade Biosciences Inc

Name	Title
Mr. Jonathan Quick	Senior Vice President of Finance
Ms. Sandy Lewis	Senior Vice President, Biometrics & Clinical Strategy
Dr. Jason Wright Ph.D.	Senior Vice President, Chemistry, Manufacturing & Controls
Mr. Bradford D. Dahms Ph.D.	Chief Financial Officer
Dr. Andrew James King D.V.M., Ph.D.	Chief Scientific Officer & Head of R&D
Ms. Elizabeth Balta	General Counsel & Corporate Secretary
Ms. Lori Stewart	Senior Vice President of People
Ms. Valerie Fauvelle	Senior Vice President of Regulatory & Quality
Ms. Amy Sullivan	Senior Vice President of Development Operations
Mr. Tom Frohlich	CEO & Director

FAQs

What is Jade Biosciences Inc share price today?

Jade Biosciences Inc share price today is $6.97 as on September 18, 2025 at 1:29 am IST at the close of the market. Jade Biosciences Inc share today touched a day high of $7.37 and a low of $6.94.

What is the 52 week high and 52 week low for Jade Biosciences Inc share?

Jade Biosciences Inc share touched a 52 week high of $13.5 on April 29, 2025 and a 52 week low of $6.57 on June 13, 2025. Jade Biosciences Inc stock price today i.e. September 18, 2025 at 1:29 am IST is closed at $6.97,which is 48.37% down from its 52 week high and 6.17% up from its 52 week low.

What is Jade Biosciences Inc's market capitalisation today?

Jade Biosciences Inc market capitalisation is $0.00T as on September 18, 2025 at 1:29 am IST.

How to invest in Jade Biosciences Inc Stock (JBIO) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Jade Biosciences Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Jade Biosciences Inc Shares that will get you 0.2152 shares as per Jade Biosciences Inc share price of $6.97 per share as on September 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy Jade Biosciences Inc Stock (JBIO) from India?

Indian investors can start investing in Jade Biosciences Inc (JBIO) shares with as little as ₹87.816 or $1 (as of September 18, 2025 at 8:37 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Jade Biosciences Inc stock (as per the Rupee-Dollar exchange rate as on September 18, 2025 at 8:37 am IST). Based on Jade Biosciences Inc share’s latest price of $6.97 as on September 18, 2025 at 1:29 am IST, you will get 1.4347 shares of Jade Biosciences Inc. Learn more about fractional shares .